Inconsistency in Risperidone Long-Acting Injection Steady-State Plasma Levels When Switching From Deltoid to Gluteal Administration

被引：9
|
作者：
Elliott, Ellie S. R. [1 ]
Purvis, Tara L.
Nelson, Leigh Anne
Sommi, Roger W.
机构：
[1] Ctr Behav Med, Kansas City, MO 64108 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2010年 / 50卷 / 06期
关键词：
Risperidone long-acting injection; pharmacokinetics; deltoid injection; gluteal injection;
D O I：
10.1177/0091270009350622
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：721 / 724
页数：4
相关论文
共 50 条
  • [31] Equivalent switching dose from oral risperidone to risperidone long-acting injection: A 48-week randomized, prospective, single-blind pharmacokinetic study
    Bai, Ya Mei
    Chen, Tzu Ting
    Chen, Jen-Yeu
    Chang, Wen-Ho
    Wu, Bojian
    Hung, Chih Hung
    Lin, Wen Kuo
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (08) : 1218 - 1225
  • [32] PHARMACOKINETICS OF A NEW LONG-ACTING LIQUID THEOPHYLLINE PRODUCT .2. STEADY-STATE EVALUATION
    HARRISON, LI
    DEVANE, JG
    BOTTINI, PB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 152 - 152
  • [33] Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection
    Lasser, RA
    Bossie, CA
    Gharabawi, GM
    Kane, JM
    SCHIZOPHRENIA RESEARCH, 2005, 77 (2-3) : 215 - 227
  • [34] ANTIPARKINSONIAN DRUG ADMINISTRATION AND PLASMA-LEVELS OF PENFLURIDOL, A NEW LONG-ACTING NEUROLEPTIC
    CHOUINARD, G
    ANNABLE, L
    COOPER, S
    COMMUNICATIONS IN PSYCHOPHARMACOLOGY, 1977, 1 (04) : 325 - 331
  • [35] Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety
    Hawley, Chris
    Turner, Martin
    Latif, Muhammud A.
    Curtis, Vivienne
    Saleem, Packeruther T.
    Wilton, Kristina
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (01) : 37 - 46
  • [36] Effectiveness of Switching From Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres: An Open-Label, Randomized Controlled Trial
    Covell, Nancy H.
    McEvoy, Joseph P.
    Schooler, Nina R.
    Stroup, T. Scott
    Jackson, Carlos T.
    Rojas, Ingrid A.
    Essock, Susan M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2012, 73 (05) : 669 - 675
  • [37] Cost-consequences analysis of switching from oral antipsychotics to long-acting risperidone in the treatment of schizophrenia
    Esposti, L. Degli
    Sangiorgi, D.
    Ferrannini, L.
    Spandonaro, F.
    Di Turi, R.
    Cesari, G.
    Limonta, G.
    Buda, S.
    JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2012, 18 (02): : 170 - 176
  • [38] Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate
    Montalvo, Itziar
    Ortega, Laura
    Lopez, Xavi
    Sole, Montse
    Monseny, Rosa
    Franch, Joan
    Vilella, Elisabet
    Labad, Javier
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (01) : 46 - 49
  • [39] Change in prepulse inhibition after switching schizophrenic patients from zuclopenthixol to long-acting injectable risperidone
    Rubio, G
    del Manzano, BA
    Ducaju, M
    Martínez-Gras, I
    Gimeno, D
    Borrel, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S475 - S475
  • [40] COMPARISON OF 2 LONG-ACTING THEOPHYLLIN PREPARATIONS - SERUM CONCENTRATION MEASUREMENTS IN STEADY-STATE - EFFECT AND COMPATIBILITY
    SCHOCH, C
    MENZ, G
    VIRCHOW, C
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1986, 69 : A152 - A152
12345